化合物AWL-II-38.3 T38511

Product Introduction
Bioactivity


英文名: AWL-II-38.3

描述: AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2].

体外活性: AWL-II-38.3 fits to LIMK2 and LIMK1 ATP-binding and substrate-binding pockets [2] .

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 65 mg/mL (138.47 mM)


关键字: inhibit | AWL II 38.3 | AWL-II-38.3 | LIMK1 | Inhibitor | LIMK2 | EphA3 | ATP | AWLII38.3

相关产品: Dasatinib monohydrate | Tesevatinib | 123C4 | Tivozanib | KYL acetate(676657-00-4 free base) | JI-101 | NVP-BHG712 | Sitravatinib | NVP-BHG712 isomer | UniPR505

相关库: Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Bioactive Compound Library

化合物AWL-II-38.3 T38511信息由TargetMol中国为您提供，如您想了解更多关于化合物AWL-II-38.3 T38511报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途